ABOS - Acumen Pharmaceuticals, Inc.
0.9801
-0.020 -2.030%
Share volume: 129,708
Last Updated: 05-09-2025
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
-0.03%
PREVIOUS CLOSE
CHG
CHG%
$1.00
-0.02
-0.02%
Summary score
31%
Profitability
35%
Dept financing
4%
Liquidity
43%
Performance
30%
Sector
Manufacturing
Industry
Pharmaceutical Products/Biological Products, Except Diagnostic Substances
Long-term ratios 31-Dec-2020 - 31-Dec-2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
0%
Return on assets
-7.59%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
9.01%
Debt ratio change over timeo
0%
Current Ratio
24.42%
Quick Ratio
0%
Cash Position Ratio
11.78%
Short-term ratios 31-Dec-2023 - 31-Dec-2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
-10.62%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
17.77%
Debt ratio change over timeo
0%
Current Ratio
16.11%
Quick Ratio
0%
Cash Position Ratio
3.23%
Last quarter ratios 31-Dec-2024
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
-16.36%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
23.92%
Debt ratio change over time
0%
Current Ratio
6.46%
Quick Ratio
0%
Cash Position Ratio
1.29%
Performance ratios (change over 4 years) 31-Dec-2020 - 31-Dec-2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | ABOS | AMGN | GILD | BNTX |
|---|---|---|---|---|
| Return on equity | 0% | 18.63% | 6.54% | 16.49% |
| Return on assets | -7.59% | 3.07% | 3.1% | 15.3% |
| Return on sales | 0% | 30.43% | 28.58% | 7.81% |
| Return on invested capital | 0% | 5.33% | 3.53% | -56.8% |
| Profitability | 0% | 80% | 54% | 54% |
| Total debt ratio | 9.01% | 92.23% | 67.28% | 20.78% |
| Debt ratio change over time | 0% | 20.48% | 134.64% | -1.07% |
| Dept financing | 2% | 29% | 43% | 6% |
| Current Ratio | 16.11% | 1.32% | 1.27% | 11.38% |
| Quick Ratio | 0% | 0.95% | 1.11% | 11.16% |
| Cash Position Ratio | 3.23% | 0.47% | 0.47% | 5.59% |
| Liquididy | 50% | 9% | 7% | 40% |
| Short-term ratios | ABOS | AMGN | GILD | BNTX |
|---|---|---|---|---|
| Return on equity | 0% | 0% | 0% | -1.58% |
| Return on assets | -10.62% | 2.13% | 0.76% | -2.3% |
| Return on sales | 0% | 21.39% | 4.39% | -272.71% |
| Return on invested capital | 0% | 0% | 0% | -13.26% |
| Profitability | 50% | 50% | 14% | 0% |
| Total debt ratio | 17.77% | 93.35% | 67.02% | 10.28% |
| Debt ratio change over time | 0% | 0% | 15.75% | -0.69% |
| Dept financing | 5% | 25% | 43% | 3% |
| Current Ratio | 16.11% | 1.32% | 1.27% | 11.38% |
| Quick Ratio | 0% | 0.95% | 1.11% | 11.16% |
| Cash Position Ratio | 3.23% | 0.47% | 0.47% | 5.59% |
| Liquididy | 39% | 6% | 7% | 68% |
